Skip to main content
OpenTrials

Clinical trial condition

Varicella Zoster Virus Infection

Explore clinical trials studying Varicella Zoster Virus Infection. Study availability and eligibility vary by location and protocol.

340 public trials 40 recruiting studies
Refine in advanced search Browse all conditions

Varicella Zoster Virus Infection trial results

Completed

Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™

NCT00353288

Conditions
Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations
  • GSK Investigational Site Ancenis, France
  • GSK Investigational Site Boulogne, France
  • GSK Investigational Site Dax, France
  • GSK Investigational Site Draguignan, France
View all 39 locations
View Trial Details
Completed

Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™

NCT00352898

Conditions
Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations
  • GSK Investigational Site Edmonton, Alberta, Canada
  • GSK Investigational Site Vancouver, British Columbia, Canada
  • GSK Investigational Site Halifax, Nova Scotia, Canada
  • GSK Investigational Site Enna, Sicily, Italy
View Trial Details
Completed

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

NCT00127010

Conditions
Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations
  • GSK Investigational Site Brussels, Belgium
  • GSK Investigational Site Leuven, Belgium
  • GSK Investigational Site Bad Saulgau, Baden-Wurttemberg, Germany
  • GSK Investigational Site Bönnigheim, Baden-Wurttemberg, Germany
View all 48 locations
View Trial Details
Completed

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

NCT00127023

Conditions
Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations
  • GSK Investigational Site Bad Saulgau, Baden-Wurttemberg, Germany
  • GSK Investigational Site Bönnigheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Bretten, Baden-Wurttemberg, Germany
  • GSK Investigational Site Ehingen, Baden-Wurttemberg, Germany
View all 85 locations
View Trial Details
Completed

Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine

NCT00406211

Conditions
Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations
  • GSK Investigational Site Klagenfurt, Austria
  • GSK Investigational Site Neufeld/Leitha, Austria
  • GSK Investigational Site Salzburg, Austria
  • GSK Investigational Site Villach, Austria
View all 41 locations
View Trial Details

Related conditions